WHO’s director of antimicrobial resistance, Dr Yvan Hutin, says science needs to catch up with drug-resistant bacteria.

A new synthetic antibiotic appears to be effective against deadly drug-resistant pathogens, a timely development in the scramble to find solutions for the growing problem of antimicrobial resistance.

Race for new antibiotics intensifies as WHO warns drug pipeline remains thin, and remains structurally unfit to support antibiotic innovation ...

Candida auris has emerged as a formidable global health threat, largely due to its propensity for multidrug resistance and hospital-acquired transmission. This fungal pathogen challenges conventional ...

Multidrug-resistant bacterial infections that cannot be treated by any known antibiotics pose a serious global threat. A research team has now introduced a method for the development of novel ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Multidrug resistance in Gram-negative bacteria represents a major public health challenge, with these organisms evolving a myriad of mechanisms to evade the effects of antibiotic treatment. One ...

Researchers have sequenced an ice cave bacterial strain, contributing to our understanding of antimicrobial resistance.

In recent years, the World Health Organization (WHO) has repeatedly warned of the increase in microbes resistant to antibiotics. Especially multi-resistant bacteria threaten the global healthcare ...

​As per WHO data, AMR is an urgent global public health threat, killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019.

A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and Clinical Translation, published in the journal Antibiotics, examines how ...